Health Care
McKesson's Q1 FY2027 revenue grew 8% due to pharmaceutical and specialty sales, but earnings per share fell 18% as a $293 million noncontrolling interest charge from the Medical-Surgical Solutions separation overshadowed operating gains.
Key risk: Opioid Litigation and Regulatory Risk
Ongoing opioid-related claims represent a material liability, with adjustments to estimated settlement liabilities continuing; a $34M credit this quarter reflects changes in estimates, but significant exposure remains.
Other Health Care Distributors companies